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Abstract 1-[(4-Methylphenyl)oxy]pyrrolidine-2,5-dione
and 1-[(4-methylphenyl)oxy]piperidine-2,6-dione react in a
Lossen-type reaction with primary alcohols in the presence
of triethylamine to furnish corresponding Na-urethane-
protected b-alanine and c-aminopropionic acid (GABA),
respectively, with excellent yields and purities, in an
essentially ‘‘one-pot’’ procedure.
Keywords N-Hydroxyimides  Lossen rearrangement 
b- and c-Amino acids  Na-Urethane-protection  CBz 
GABA  b-Alanine  Anthranilic acid
Introduction
Sulfonic esters of N-hydroxyimides are well known for
their inhibitory properties against serine proteases, mainly
human leukocyte elastase (HLE) (Abell and Oldham 1999;
Groutas et al. 1986, 1992, 1993, 1994; Neumann and
Guetschow 1994; Tirouvanziam 2006). It has been eluci-
dated that the mechanism of the proteases inhibition is based
on the Lossen-like rearrangement (Groutas et al. 1986),
which is induced by the nucleophilic amino acid residues
present in the enzyme’s active center, like the hydroxyl side
group of serine. Moreover, many investigations have shown
that sulfonic esters of N-hydroxyimides are characterized
also by the specific chemical reactivity toward nucleophilic
compounds, like amines (Bauer and Exner 1974; Youssef
and Abbady 1997; Abbady et al. 2000), hydrazine (Youssef
and Abbady 1997; Abbady et al. 2000) and alcohols
(Youssef and Abbady 1997; Chandrasekhar and Sridhar
2000; Sheikh et al. 2010). These properties may be at least
partially explained as a result of flattened pyramidal
geometry of the succinic ring’s nitrogen atom (Stefanowicz
et al. 2006). This structural feature is common for every
described sulfonic ester of N-hydroxyimide (Stefanowicz
et al. 2005, 2006, 2007). The Lossen-like reaction between
the nucleophiles and sulfonic esters of N-hydroxyimides
(Fig. 1) opens a new route for the efficient one-pot synthesis
of Na-urethane-protected compounds. Since the urethane
groups are often used as protective groups, the rearrange-
ment products may be applied as building blocks in the
synthesis of peptidomimetics.
We present here such a method of synthesis of Na-ure-
thane-protected b-alanine and GABA and also anthranilic
acid derivatives, based on the nucleophiles which induce
the Lossen-like rearrangement.
b-Alanine is an essential non-proteinaceous amino acid,
which can be considered as an important element of some
peptidic (English et al. 2006; Koyack and Cheng 2006;
Kritzer et al. 2005; Patch and Barron 2002; Porter et al.
2005; Potocky et al. 2005; Qiu et al. 2006) and pepti-
domimetic chains (Ranganathan et al. 1997). b-Amino
acids-containing peptides exhibit well-defined secondary
structures in solution, such as helices, turns, and sheets.
Such peptides can also mimic a c-turn conformation, which
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occurs in the case of the cis-proline residue (Ahmed et al.
2007; Cheng et al. 2001; Daura et al. 2001; Langenhan
et al. 2003). The GABA regulates the growth of embryonic
and neural stem cells. GABA activates the GABAA
receptor, causing cell cycle arrest in the S-phase, limiting
their growth (Wang et al. 2008).
Experimental section
Investigated compounds were synthesized according to the
procedures described below. Melting points (uncorrected)
were measured with a Boethius PHMK (VEB Analytik,
Dresden, Deutschland) apparatus. The 1H and 13C NMR
spectra were recorded on a 500 MHz Bruker spectrometer
using TMS as the internal standard. Mass spectra were
obtained on a micrOTOF-Q—Bruker Daltonic instrument
equipped with an electrospray ion source. MeOH contain-
ing 10-4 M NaCl or 10-2 M NH4HCO3 was used as a
solvent for ESI–MS measurements.
All solvents and reagents were used as supplied.
Methanol, ethyl acetate, benzyl alcohol, hydrochloric acid
and triethylamine (TEA) were obtained from Sigma-
Aldrich. Methanol, used for ESI–MS measurements, was
LC–MS quality and obtained from Merck Millipore. Sol-
vents used for NMR experiments (CDCl3 and DMSO-d6)
were obtained from Cambridge Isotope Laboratories.
General procedure for synthesis of sulfonic esters of
N-hydroxyimides (Stefanowicz et al. 2005, 2006, 2007;
Sheikh et al. 2010)
N-Hydroxyimide (93 mmol) and chloride of sulfonic acid
(100 mmol) were dissolved in tetrahydrofuran (100 ml)
and then triethylamine (14.70 ml) was added dropwise for
20 min. After 40 min, the solvent was removed in vacuo
and 100 ml of 5 % hydrochloric acid was added. The
product was filtered off, washed twice with water and
crystallized from ethyl acetate to give corresponding
sulfonic ester of N-hydroxyimide.
1-{[(4-Methylphenyl)sulfonyl]oxy}pyrrolidine-2,5-dione
(Stefanowicz et al. 2006) (TosOSu) 1a. mp = 143–144 C,
lit (Stefanowicz et al. 2006) 135–136 C (Sheikh et al. 2010).
ESI–MS: Found: 292.02; calculated for (C11H11NO5S ?
Na)? 292.03, 1H NMR (CDCl3, 500 MHz) d 2.44 (s, 3H),
2.76 (s, 4H), 7.35 (d, 2H, J = 8.4 Hz), 7.87 (d, 2H,
J = 8.4 Hz). 92 % yield.
1-{[(4-Methylphenyl)sulfonyl]oxy}piperidine-2,6-dione
(TosOGlt) 1b. mp = 148–148,5 C, lit (Sheikh et al. 2010)
145.5–146 C. ESI–MS: Found: 306.04; calculated for
(C12H13NO5S ? Na)
? 306.04. 1H NMR (DMSO-d6,
500 MHz) d 1.87 (q, 2H, J = 6.37 Hz), 2.44 (s, 3H), 2.73
(t, 4H, J = 6.40 Hz), 7.48 (d, 2H, J = 8.30 Hz), 7.85 (d,
2H, J = 8.30 Hz). 13C NMR (DMSO-d6, 125 MHz) d 15.8
(CH3), 32.7 (C=OCH2), 39.7 (CH2), 168.0 (CH2C=O).
Yield 70 %.
1-[(Methylsulfonyl)oxy]pyrrolidine-2,5-dione (MesOSu)
1c. mp = 157–158 C, lit (Stefanowicz et al. 2007)
157–158 C. ESI–MS: Found: 216.00; calculated for
(C5H7NO5S ? Na)
? 215.99. 1H NMR (DMSO-d6,
500 MHz) d 2.77 (t, 4H, J = 7.06 Hz), 3.59 (s, 3H). 13C
NMR (DMSO-d6, 125 MHz) d 25.5 (CH3), 39.7
(CH2CH2), 170.2 (C=O). Yield 64 %.
1-[(Methylsulfonyl)oxy]piperidine-2,6-dione (MesOGlt)
1d. mp = 138–139 C, ESI–MS: Found: 230.00; calcu-
lated for (C6H9NO5S ? Na)
? 230.01. 1H NMR (DMSO-
d6, 500 MHz) d 1.90 (q, 2H, J = 6.36), 2.82 (t, 4H,
J = 6.42), 3.47 (s, 3H). 13C NMR (DMSO-d6, 125 MHz) d
15.8 (CH3), 32.7 (C=OCH2), 39.7 (CH2), 168.0 (CH2C=O).
Yield 65 %.
2-{[(4-Methylphenyl)sulfonyl]oxy}-1H-isoindole-1,3
(2H)-dione (TosOPh) 1e. mp = 155–157 C, lit (Stef-
anowicz et al. 2006) 154–157 C, lit (Sheikh et al. 2010)
161.0–161.5 C. ESI–MS: Found: 340.02; calculated for
(C15H11NO5S ? Na)
? 340.03. 1H NMR (CDCl3,































Fig. 1 A proposed reaction mechanism between the sulfonic esters of N-hydroxyimides and nucleophile (:NuH, e.g. alcohols, amines) (Groutas
et al. 1986)
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(m, 2H), 7. 85 (m, 2H) 7.93 (d, 2H, J = 8.3 Hz)., 91 %
yield.
Synthesis of N-urethane-protected amino acids
Benzyl alcohol as a reaction substrate and as a solvent
(compound 2a-c)
Sulfonic esters of N-hydroxyimides (1a-d, 1.0 g) were
dissolved in 4.5 ml of benzyl alcohol. Later 2.2 ml of tri-
ethylamine (TEA) was added dropwise to the solution. The
reaction mixtures were stirred at 65 C for 1 h. The reac-
tion product was diluted with 60 ml of methanol. Next
5 ml of 1 M methanolic NaOH solution was added and the
mixtures were incubated for 1 h. The solvent was removed
in vacuo and residue was dissolved in 50 ml of water. The
solution was acidified to pH 1 with 5 N HCl. The product,
which partially had crystallized, was extracted with ethyl
acetate and solvent was evaporated in vacuo.
Trifluoroethanol as a substrate and as a solvent
(compound 3a,b)
TosOSu or TosOGlt (1a, b 1.0 g) was dissolved in 4.5 ml
of benzyl alcohol. TEA (triethylamine; 2.2 ml) was added
dropwise to the solution. The reaction mixture was stirred
at 65 C for 1 h. The excess of alcohol was removed in
vacuum. The reaction product was extracted with ethyl
acetate, washed with 5 % hydrochloric acid and water. The
organic layer was evaporated in vacuo to obtain oily
residue.
4-Chlorobenzyl alcohol and 4-methoxybenzyl alcohol
as a substrate and as a solvent (compound 4a,b
and 5a,b, respectively)
TosOSu or TosOGlt (1a,b 1,0 g) was added to 4.5 g/4.5 g
of 4-chlorobenzyl/4-methoxybenzyl alcohol. Later 2.2 ml
of TEA was added dropwise. The reaction mixture was
stirred at 65 C for 1 h. The reaction gives a product which
was then diluted with 60 ml of methanol and hydrolyzed
with the addition of 5 ml of 1 M methanolic NaOH solu-
tion. Then the reaction mixture was acidified to pH 1 with
5 N HCl. The product was extracted with ethyl acetate
which was subsequently removed in vacuo.
Benzene as a solvent
TosOSu or TosOGlt (1a,b; 1.0 g) was dissolved in 10 ml
of benzene and 2.5 ml of benzyl alcohol was added. Later
1.5 ml of TEA was added dropwise. The reaction mixture
was stirred at 65 C for 1 h. Then the mixture was diluted
with 30 ml of methanol and after addition of 2.5 ml of 1 M
methanolic NaOH solution was incubated for 1 h. The
solvent was removed in vacuo and the residue was dis-
solved in 25 ml of water. After being acidified to pH 1 with
5 N HCl, the partially crystallized product was extracted
with ethyl acetate. The solvent was evaporated in vacuo.
The residue was dissolved in 25 ml of water and acidified
to pH 1 with 5 N HCl. The product, which partially had
crystallized, was extracted with ethyl acetate and solvent
was evaporated in vacuo.
Analytical data for obtained products
4-{[(Benzyloxy)carbonyl]amino}propanoic acid (N-[(ben-
zyloxy)carbonyl]-beta-alanine) (2a). mp = 99–100 C.
ESI–MS: Found: 222.07; calculated for (C11H13NO4–H)
-
222.08. 1H NMR (500 MHz, CDCl3): d = 2.58 ppm
(t, J = 6.85 Hz, 2H); 3.44 ppm (q, J = 5.10 Hz, 2H);
5.00 ppm (s, 2H); 5.30 ppm (broad signal, 0.78H);
6.31 ppm (broad signal, 0.22H); 7.29–7.34 ppm (m, 5H);
9.49 ppm (broad signal. 1H). 1H NMR (500 MHz, DMSO-
d6): d = 2.39 ppm (t, J = 6.72 Hz, 2H); 3.20 ppm (m,
2H); 5.08 ppm (s, 2H); 7.27 ppm (t, J = 5.30 Hz, 1H);
7.29–7.34 ppm (m, 5H).
4-{[(Benzyloxy)carbonyl]amino}butanoic acid (2b).
mp = 61–62 C. ESI–MS: Found: 236.09; calculated for
(C12H15NO4–H)
- 236.19. 1H NMR (500 MHz, CDCl3):
d = 1.83 ppm (m, J = 6.92 Hz, 2H); 2.39 ppm (t,
J = 7.00 Hz, 2H); 3.25 ppm (q, J = 6.42 Hz, 2H);
4.88 ppm (s, 1H); 5.08 ppm (s, 2H); 7.29–7.34 ppm (m,
5H); 9.49 ppm. 1H NMR (500 MHz, DMSO-d6):
d = 1.61 ppm (m, 2H); 2.20 ppm (t, J = 9.58 Hz, 2H);
3.00 ppm (q, J = 6.02 Hz, J = 6.13 Hz, 2H); 4.99 ppm (s,
2H); 7.31 ppm (d, J = 7.42 Hz, 2H); 7.32-7.35 ppm (m,
5H); 9.49 ppm.
2-{[(Benzyloxy)carbonyl]amino}benzoic acid (2c). mp =
110–112 C. ESI–MS: Found: 270.07; calculated for
(C15H13NO4–H)
- 270.08. 1H NMR (500 MHz, DMSO-
d6): d = 5.17 ppm (broad signal, 2H).; d = 7.10 ppm (m,
1H); 7.33–7.43 (m, 5H) ppm; 7.59 ppm (t, J = 8.53 Hz,
1H); 7.96 ppm (d, J = 7.96 Hz, 1H); 8.26 ppm (t,
J = 8.26 Hz, 1H).
2,2,2-Trifluoroethyl 3-{[(2,2,2-trifluoroethoxy)carbonyl]
amino}propanoate (3a). mp = 33 C. ESI–MS: Found:
320.03; calculated for (C8H9F6NO4 ? Na)
? 320.02. 1H
NMR (500 MHz, CDCl3): d = 2.64 ppm (t, J = 6.08 Hz,
2H); 3.46 ppm (q, J = 6.11 Hz, 2H); 4.39 ppm (q,
3 J = 8.52 Hz, 2H); 4.44 ppm (q, J = 8.42 Hz, 2H);
5.68 ppm (broad signal, 1H). 1H NMR (500 MHz, DMSO-
d6): d = 2.61 ppm (t, J = 6.73 Hz, 2H); 3.26 ppm (q,
J = 6.96 Hz, 1H); 4.63 ppm (q, 3 J = 9.04 Hz, 2H);
7.74 ppm (broad signal, 1H).
2,2,2-Trifluoroethyl 4-{[(2,2,2-trifluoroethoxy)carbonyl]
amino}butanoate (3b). mp = 30 C. ESI–MS: Found:
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334.05; calculated for (C9H11F6NO4 ? Na)
? 334.05. 1H
NMR (500 MHz, CDCl3): d = 1.84 ppm (m, J = 7.06 Hz,
2H); 2.43 ppm (t, J = 7.30 Hz, 2H); 3.23 ppm (q,
3 J = 6.57 Hz, 2H); 4.38–4.44 ppm (m, 3 Hz, 4H);
5.40 ppm (broad signal, 1H). 1H NMR (500 MHz, DMSO-
d6): d = 1.73 ppm (m, J = 7.18 Hz, 2H); 2.44 ppm (t,
J = 7.46 Hz, 2H); 3. 06 ppm (q, J = 6.01 Hz, 2H);
4.62 ppm (q, J = 9.12 Hz); 7.65 ppm (broad signal, 1H).
3-({[(4-Methoxybenzyl)oxy]carbonyl}amino)propanoic
acid (5a). mp = 79–81 C. ESI–MS: Found: 252.09; cal-
culated for (C12H15NO5–H)
- 252.09. 1H NMR (500 MHz,
CDCl3): d = 2.56 ppm (t, J = 2 Hz, 2H); 3.42 ppm (mul-
tiplet, 2H); 3.78 ppm (s, 3H); 5.00 ppm (s, 0.56H); 5.06 ppm
(s, 1.44H); 5.28 ppm (s, 0.72H); 6.29 ppm (s, 0.28H);
6.85 ppm (d, J = 7.89 Hz, 2H); 7.26 ppm (d, J = 7.90 Hz,
2H); 8.70–9.65 ppm (broad signal, 1H). 1H NMR (500 MHz,
DMSO-d6): d = 2.34 ppm (t, J = 6.94 Hz, 2H); 3.15 ppm
(quartet, J = 6.60, J = 6.28, 2H); 3.70 ppm (s, 3H);
4.88 ppm (s, 2H); 6.87 ppm (d, J = 8.41 Hz, 2H); 7.16 (t,
J = 6.18 Hz, 1H); 7.24 ppm (d, J = 8.41 Hz, 2H).
4-({[(4-Methoxybenzyl)oxy]carbonyl}amino)butanoic
acid (5b). mp = (liquid at RT). ESI–MS: Found: 266.10;
calculated for (C13H17NO5–H)
- 266.09. 1H NMR
(500 MHz, CDCl3): d = 1.94 ppm (m, J = 7.83 Hz,
J = 7.74 Hz, 2H); 2.39 ppm (t, J = 6.33 Hz, 2H); 2.80 ppm
(q, J = 7.48 Hz, 2H); 3.69 ppm (s, 3H); 4.50 ppm (s, 2H);
6.89 ppm (d, J = 7.20 Hz, 2H); 7.36 ppm (d, J = 7.70 Hz,
2H); 5.86 ppm (broad signal, 1H). 1H NMR (500 MHz,
DMSO-d6): d = 1.72 ppm (m, J = 7.33 Hz, J = 7.54 Hz,
2H); 2.29 ppm (t, J = 7.30 Hz, 2H); 2.77 ppm (q,
J = 7.28 Hz, 2H); 3.63 ppm (s, 3H); 4.57 ppm (s, 2H);
7.09 ppm (d, J = 7.70 Hz, 2H); 7.45 ppm (d, J = 7.75 Hz,
2H); 7.66 ppm (broad signal, 1H).
3-({[(4-Chlorobenzyl)oxy]carbonyl}amino)propanoic
acid (4a). mp = 119–120 C. ESI–MS: Found: 256.04;
calculated for (C12H14ClNO4–H)
- 256.04. 1H NMR
(500 MHz, CDCl3): d = 2.61 ppm (t, J = 3 Hz, 2H);
3.48 ppm (m, 2H); 5.07 ppm (s, 2H); 5.28-542 ppm (broad
signal, 0.89H); 6.18–6.30 ppm (broad signal, 0.11H);
7.28 ppm (d, 3 J = 8.40 Hz, 2H); 7.33 ppm (d, J =
8.40 Hz, 2H). 1H NMR (500 MHz, DMSO-d6): d = 2.37
ppm (t, J = 6.76 Hz, 2H); 3.19 ppm (q, J = 6.28,
3 J = 6.18, 2H); 4.98 ppm (s, 2H); 7.31 ppm (t,
J = 6.18 Hz, 1H); 7.36 ppm (d, J = 7.39 Hz, 2H);
7.41 ppm (d, J = 7.41 Hz, 2H).
4-({[(4-Chlorobenzyl)oxy]carbonyl}amino)butanoic
acid (4b). mp = 100C. ESI–MS: Found: 270.05; calculated
for (C12H14ClNO4–H)
- 270.06. 1H NMR (500 MHz,
CDCl3): d = 1.86 ppm (m, J = 6.96 Hz, 2H); 2.41 ppm
(t, J = 7.10 Hz, 2H); 3.27 ppm (t, J = 6.75 Hz, 2H);
5.08 ppm (s, 2H); 5.90–5.08 ppm (broad signal, 0.10H);
7.05–7.25 ppm (broad signal, 0.90H); 7.29 ppm (d,
J = 8.40 Hz, 2H); 7.33 ppm (d, J = 8.40 Hz, 2H). 1H NMR
(500 MHz, DMSO-d6): d = 1.52 ppm (m, J = 6.79 Hz,
J = 6.77 Hz, 2H); 2.11 ppm (t, J = 7.02 Hz, 2H); 2.91 ppm
(q, J = 5.73 Hz, 2H); 4.90 ppm (s, 2H); 7.21 ppm (t,
J = 5.90 Hz, 1H); 7.27 ppm (d, J = 7.80 Hz, 2H);
7.32 ppm (d, J = 7.81 Hz, 2H).
Results and discussion
b and c dicarboxylic acids may be relatively easily con-
verted to cyclic N-hydroxyimides. These cyclization
products are often used as the additives in peptide synthesis
and for activation of carboxylic group in the modification
of proteins. N-hydroxyimides also react with aromatic and
aliphatic sulfochlorides forming crystalline derivatives
with high yield. In this paper, we tested a new way of
synthesis of N-protected non-proteinaceous amino acids
based on Lossen rearrangement. Reaction of sulfonic ester
of N-hydroxyimide and selected alcohol is carried out in
the presence of triethylamine at 65 C. As the solvents we
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Table 1 The yields of synthesis
of N-a-urethane-protected
b- and c-amino acids
Na-urethane-protected b- and c-amino acids 1089
123
The aryl- and alkylsulfonates of hydroxyimides form the
product I, which is next hydrolyzed with 1 M methanolic
NaOH solution forming N-urethane-protected amino acid.
Then the reaction mixture is acidified to pH 1 with 5 M
HCl and the product II crystallizes spontaneously or is
extracted with ethyl acetate which is subsequently removed
in vacuo (Fig. 2). The yield of b-alanine derivatives syn-
thesized by this procedure is in the range of 38–82 %. The
lowest yield is obtained when benzene is used as a solvent
(38 %), the highest—when 4-methoxybenzyl alcohol is
used (82 %). However, all the results are much higher than
those obtained for other reported methods of synthesis of
b-alanine-containing compounds (Ranganathan et al.
1997).
The same procedure was also tested on secondary and
tertiary alcohols; however, the attempt on the isolation of
reaction product was unsuccessful. The obtained results
show clearly that the rearrangement occurs only with pri-
mary alcohols, like benzyl alcohol and its derivatives.
Performing the reaction under reflux with the addition of
pyridine as a base does not give any rearrangement prod-
ucts either.
Reactions were also performed in a microwave oven
using conditions analogical to those shown above; how-
ever, the yields were not higher than when conventional
heating was used (data not presented).
Application of triethylamine as a base in benzene sol-
vent results in the yields which are in the range of 31–38 %
(Table 1). The highest reaction yield was obtained in
alcohol, which plays a double role as a solvent and as a
reaction substrate, in presence of triethylamine (Table 1).
The reaction described in this paper can also be used for
synthesis of anthranilic acid N-urethane-protected deriva-
tives (Fig. 3). However, the yield of this reaction does not
exceed 31 %.
Conclusion
The simple one-pot procedure proposed in this study pro-
vides a new less time-consuming and relatively cheap way of
obtaining Na-urethane-protected b-alanine and c-amino-
propionic acid (GABA) derivatives from stable and easily
available substances, like primary alcohols and sulfonic
esters of N-oxyimides. Reaction is limited to primary alco-
hols. The crude products obtained in this route are ready for
further synthesis without additional purification.
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